[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@SnupSnus](/creator/twitter/SnupSnus) "@JialiangLiang @seedy19tron I am not saying that there's a "safety issue" w Rinvoq but it carries a (class) black box (a class too IRCC) CV-mortality label and all in all just compare the AE's -ENTYVIO might be the closest to pbo like safety in drug development we got so far-this is why it's King in IBD"  [@SnupSnus](/creator/x/SnupSnus) on [X](/post/tweet/1948965314453971089) 2025-07-26 04:35:15 UTC 1643 followers, XXX engagements "That's a crazy move for largish pharma lost in the Abivax drama $TLX is the SEC probe reallY that had and what is it about might pay to find out"  [@SnupSnus](/creator/x/SnupSnus) on [X](/post/tweet/1948167979281137886) 2025-07-23 23:46:56 UTC 1643 followers, XXX engagements "That's nice for Takeda (congrats @Tatsu_Fujimoto 🎉) and should read positively for the whole class & $CNTA $ALKS $CNTA data soon too been a long wait"  [@SnupSnus](/creator/x/SnupSnus) on [X](/post/tweet/1944828631831773526) 2025-07-14 18:37:33 UTC 1643 followers, 1275 engagements "@Andre_AGTC I like-correct me if I am wrong- how your portfolio is so focused on the lifeblood of the sector: the buyout Notably absent $CYTK and radiopharma- is that for specific reasons"  [@SnupSnus](/creator/x/SnupSnus) on [X](/post/tweet/1948185622272700907) 2025-07-24 00:57:02 UTC 1643 followers, XXX engagements "Reduced $BBIO a bit (1/5 -now just shy of 20%) and added some $NAMS- the Alz data (remember: w.o. cognition or brain imaging) might be Meme moment. not sure tbh about Overall and CVOT prospects -even though I have been doing loads of reading-"  [@SnupSnus](/creator/x/SnupSnus) on [X](/post/tweet/1948766537592012845) 2025-07-25 15:25:23 UTC 1643 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SnupSnus
"@JialiangLiang @seedy19tron I am not saying that there's a "safety issue" w Rinvoq but it carries a (class) black box (a class too IRCC) CV-mortality label and all in all just compare the AE's -ENTYVIO might be the closest to pbo like safety in drug development we got so far-this is why it's King in IBD"
@SnupSnus on X 2025-07-26 04:35:15 UTC 1643 followers, XXX engagements
"That's a crazy move for largish pharma lost in the Abivax drama $TLX is the SEC probe reallY that had and what is it about might pay to find out" @SnupSnus on X 2025-07-23 23:46:56 UTC 1643 followers, XXX engagements
"That's nice for Takeda (congrats @Tatsu_Fujimoto 🎉) and should read positively for the whole class & $CNTA $ALKS $CNTA data soon too been a long wait" @SnupSnus on X 2025-07-14 18:37:33 UTC 1643 followers, 1275 engagements
"@Andre_AGTC I like-correct me if I am wrong- how your portfolio is so focused on the lifeblood of the sector: the buyout Notably absent $CYTK and radiopharma- is that for specific reasons" @SnupSnus on X 2025-07-24 00:57:02 UTC 1643 followers, XXX engagements
"Reduced $BBIO a bit (1/5 -now just shy of 20%) and added some $NAMS- the Alz data (remember: w.o. cognition or brain imaging) might be Meme moment. not sure tbh about Overall and CVOT prospects -even though I have been doing loads of reading-" @SnupSnus on X 2025-07-25 15:25:23 UTC 1643 followers, XXX engagements